HDAC3 and diabetes mellitus: This notion is supported by the finding of histone deacetylase 3 (HDAC3) as the most significantly altered epigenetic regulator in atherosclerotic lesion’s macrophages in human patients with diabetes and the attenuation of atherosclerotic plaques with depletion of HDAC3 in mice models.